Researchers found that 8.3% of US adults had at least one major depressive episode. In adolescents, the rate was 20.1%, with 29.2% of female adolescents reporting a major depressive episode. Major ...

The US FDA has approved lumateperone (Caplyta, Johnson & Johnson) for use as adjunctive therapy with antidepressants for the treatment of adults with major depressive disorder (MDD). The approval of ...

Globally, over 280 million people have depression. But if you were to ask a random sample of 1,000 people to describe their depression, you would have a low chance of finding two people who have the ...

In a recent study published in JAMA Network Open, researchers explored how structural and functional aspects of the brain, as seen through neuroimaging, differ between individuals with high exposure ...